FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3205111000001108: Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1746281000001110 Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1746291000001112 Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Is a Rizatriptan 10mg oral lyophilisates sugar free 3 tablet true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Is pack of Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has active ingredient Rizatriptan benzoate false Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has active ingredient Rizatriptan false Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has excipient Aspartame false Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has AMP Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has dispensed dose form Conventional release oral lyophilisate true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start